Literature DB >> 23921093

Obstetrical outcome of young women with a past history of cerebral venous thrombosis.

Jonathan Ciron1, Gaëlle Godenèche, Xavier Vandamme, Marie-Pierre Rosier, Igor Sharov, Stéphane Mathis, Delphine Larrieu, Jean-Philippe Neau.   

Abstract

BACKGROUND: This study was designed to review the obstetrical outcome of a consecutive series of cerebral venous thrombosis (CVT) affecting fertile women over a long period of time.
METHODS: From a computerized database of four hospitals of a French region (Poitou-Charentes), we selected patients admitted to hospital for CVT between January 1995 and February 2012. All the case notes were re-examined by two neurologists to confirm the initial diagnosis of CVT. The criterion of inclusion in our study was the occurrence of CVT in a woman ≤ 40 years of age. All the patients were recontacted by telephone in September 2012 and could be seen in an outpatient clinic. The data of interest were: occurrence of subsequent pregnancies, outcome of these pregnancies, their possible complications, their management with respect to preventive medication, details on the birth and the neonate.
RESULTS: Out of 190 consecutive patients hospitalized for CVT, 62 women aged ≤ 40 years were included (mean age 27.2 ± 6.7 years at the time of their cerebrovascular event). The mean duration of follow-up was 89.5 ± 60.6 months (median: 76 months). There were 45 pregnancies in 24 of the women. Among these 45 pregnancies, 1 was in progress, 24 were completed resulting in normal children, whereas 20 were terminated (5 voluntary abortions, 14 miscarriages and 1 medical abortion). During the pregnancies recorded, there was one recurrence of CVT and no extra-CVT. Various management strategies were adopted, depending on the identified cause(s) for CVT and the medical history of the patient.
CONCLUSIONS: Our study confirms that the occurrence of a CVT in young women is not a contraindication for subsequent pregnancy. However, it points to a high incidence of miscarriage. Apart from this fact, there is no increase in materno-fetal complications during pregnancy and childbirth, and the neonates are healthy. The risk of recurrence of a CVT or extra-CVT during subsequent pregnancy is low but most of patients were on preventive antithrombotic medication.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23921093     DOI: 10.1159/000351507

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  7 in total

1.  Long-term outcome after cerebral venous thrombosis: analysis of functional and vocational outcome, residual symptoms, and adverse events in 161 patients.

Authors:  Sini Hiltunen; Jukka Putaala; Elena Haapaniemi; Turgut Tatlisumak
Journal:  J Neurol       Date:  2016-01-02       Impact factor: 4.849

2.  Obstetrical history of women with cerebral vein thrombosis: outcome of the pregnancies before and after the thrombotic event.

Authors:  Daniela Poli; Caterina Cenci; Sophie Testa; Oriana Paoletti; Elena Silvestri; Emilia Antonucci
Journal:  Intern Emerg Med       Date:  2017-06-06       Impact factor: 3.397

Review 3.  Pregnancy complicated by neurological and neurosurgical conditions - The evidence regarding mode of delivery.

Authors:  Adam Morton
Journal:  Obstet Med       Date:  2021-04-07

Review 4.  Neuro-obstetrics: A multidisciplinary approach to care of women with neurologic disease.

Authors:  Ingrid A Brussé; Anna C M Kluivers; Maria D Zambrano; Kara Shetler; Eliza C Miller
Journal:  Handb Clin Neurol       Date:  2020

Review 5.  Diagnosis and treatment of cerebral venous and sinus thrombosis.

Authors:  Christian Weimar
Journal:  Curr Neurol Neurosci Rep       Date:  2014-01       Impact factor: 5.081

Review 6.  Cerebral venous sinus thrombosis: update on diagnosis and management.

Authors:  José M Ferro; Patrícia Canhão
Journal:  Curr Cardiol Rep       Date:  2014-09       Impact factor: 2.931

7.  Factors associated with pregnancy outcomes in women with a history of cerebral sinus venous thrombosis.

Authors:  Amihai Rottenstreich; Harel Gershgoren; Galia Spectre; Nael Da'as; Ohad S Bentur; Gabriel Levin; Yosef Kalish
Journal:  J Thromb Thrombolysis       Date:  2020-07       Impact factor: 2.300

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.